Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) and prothrombin G20210A heterozygosity: response to t-PA therapy.

Suppr

超能文献

作者信息

Antunes Joana, Filipe Paulo, André Marisa, Fraga Ana, Miltenyi Gabriel, Marques Gomes Manuel

出版信息

Acta Derm Venereol. 2010;90(1):91-2. doi: 10.2340/00015555-0760.

DOI:10.2340/00015555-0760

PMID:20107738

Abstract

摘要

相似文献

Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) and prothrombin G20210A heterozygosity: response to t-PA therapy.

Acta Derm Venereol. 2010;90(1):91-2. doi: 10.2340/00015555-0760.

Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.

Arch Dermatol. 2006 Nov;142(11):1466-9. doi: 10.1001/archderm.142.11.1466.

Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity.

J Thromb Thrombolysis. 2008 Aug;26(1):31-4. doi: 10.1007/s11239-008-0214-1. Epub 2008 Mar 23.

Successful long-term use of intravenous immunoglobulin to treat livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity.

Arch Dermatol. 2011 Oct;147(10):1224-5. doi: 10.1001/archdermatol.2011.274.

Use of intravenous tissue plasminogen activator in a 16-year-old patient with basilar occlusion.

J Child Neurol. 2008 Sep;23(9):1049-53. doi: 10.1177/0883073808319076.

Massive pulmonary embolism in pregnancy treated with tissue plasminogen activator.

Obstet Gynecol. 2005 Nov;106(5 Pt 2):1156-8. doi: 10.1097/01.AOG.0000164059.72933.9c.

Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.

J Clin Periodontol. 2007 Apr;34(4):278-84. doi: 10.1111/j.1600-051X.2007.01049.x. Epub 2007 Jan 25.

Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature.

Pathophysiol Haemost Thromb. 2010;37(1):24-9. doi: 10.1159/000319051. Epub 2010 Jul 20.

Severe venous thrombosis in an infant heterozygous for the G20210A mutation in the prothrombin gene.

Acta Paediatr. 2003 Sep;92(9):1111-3.

Leg ulcers revealing familial thrombophilia: prothrombin G20210A gene mutation and plasminogen activator inhibitor type 1 (PAI-1) polymorphism.

Eur J Dermatol. 2011 May-Jun;21(3):414-5. doi: 10.1684/ejd.2011.1287.

引用本文的文献

Livedoid vasculopathy: A multidisciplinary clinical approach to diagnosis and management.

Int J Womens Dermatol. 2021 Sep 2;7(5Part A):588-599. doi: 10.1016/j.ijwd.2021.08.013. eCollection 2021 Dec.

Livedoid vasculopathy and its association with genetic variants: A systematic review.

Int Wound J. 2021 Oct;18(5):616-625. doi: 10.1111/iwj.13563. Epub 2021 Mar 8.

From dermatological conditions to COVID-19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy.

Dermatol Ther. 2021 Jan;34(1):e14565. doi: 10.1111/dth.14565. Epub 2020 Nov 30.

Plasminogen activator inhibitor-1: a potential etiological role in livedoid vasculopathy.

Int Wound J. 2020 Dec;17(6):1902-1908. doi: 10.1111/iwj.13480. Epub 2020 Oct 11.

Painless Livedoid Vasculopathy in a Patient with G20210A Prothrombin Gene Mutation.

Case Rep Med. 2012;2012:910231. doi: 10.1155/2012/910231. Epub 2012 Sep 5.

Livedoid vasculopathy in a patient with lupus anticoagulant and MTHFR mutation: treatment with low-molecular-weight heparin.

J Thromb Thrombolysis. 2012 Nov;34(4):541-4. doi: 10.1007/s11239-012-0743-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验